Affordable Access

deepdyve-link
Publisher Website

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study.

Authors
  • Roberts, Jason A1, 2, 3, 4
  • Joynt, Gavin M5
  • Lee, Anna5
  • Choi, Gordon5
  • Bellomo, Rinaldo6
  • Kanji, Salmaan7, 8
  • Mudaliar, M Yugan9, 10
  • Peake, Sandra L11, 12, 13
  • Stephens, Dianne14, 15, 16
  • Taccone, Fabio Silvio17
  • Ulldemolins, Marta18, 19, 20
  • Valkonen, Miia Maaria21
  • Agbeve, Julius22
  • Baptista, João P23
  • Bekos, Vasileios24
  • Boidin, Clement1, 25, 26
  • Brinkmann, Alexander27
  • Buizen, Luke28
  • Castro, Pedro29, 30
  • Cole, C Louise10, 31
  • And 42 more
  • 1 The University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia. , (Australia)
  • 2 Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia. , (Australia)
  • 3 Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Australia. , (Australia)
  • 4 Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia. , (Australia)
  • 5 Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong. , (Hong Kong SAR China)
  • 6 Department of Intensive Care, Austin Hospital, Heidelberg and School of Medicine, The University of Melbourne, Melbourne, Australia. , (Australia)
  • 7 Department of Pharmacy, The Ottawa Hospital, Ottawa, Canada. , (Canada)
  • 8 The Ottawa Hospital Research Institute, Ottawa, Canada. , (Canada)
  • 9 Intensive Care Unit, Westmead Hospital, Sydney, Australia. , (Australia)
  • 10 Medical School, University of Sydney, Sydney, Australia. , (Australia)
  • 11 Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Woodville, Australia. , (Australia)
  • 12 School of Medicine, University of Adelaide, Adelaide, Australia. , (Australia)
  • 13 School of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. , (Australia)
  • 14 Intensive Care Unit, Royal Darwin Hospital, Darwin, Australia. , (Australia)
  • 15 Flinders University, Adelaide, Australia. , (Australia)
  • 16 National Critical Care and Trauma Response Centre, Darwin, Australia. , (Australia)
  • 17 Department of Intensive Care, Erasme Hospital, Brussels, Belgium. , (Belgium)
  • 18 Critical Care Department, Corporació Sanitària Parc Taulí, Sabadell, Spain. , (Spain)
  • 19 Fundació Privada Clínic per la Recerca Biomèdica, Barcelona, Spain. , (Spain)
  • 20 Infectious Diseases-Internal Medicine Departments, Bellvitge University Hospital, l'Hospitalet de Llobregat, Spain. , (Spain)
  • 21 Intensive Care Medicine, Department of Perioperative, Intensive Care, and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. , (Finland)
  • 22 Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Australia. , (Australia)
  • 23 Intensive Care Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. , (Portugal)
  • 24 Intensive Care Unit, Naval and Veterans Hospital of Athens, Athens, Greece. , (Greece)
  • 25 Université Claude Bernard Lyon 1, UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive, Lyon, France. , (France)
  • 26 Hôpital Pierre Garraud, Hospices Civils de Lyon, Lyon, France. , (France)
  • 27 Department of Anesthesia and Critical Care Medicine, General Hospital of Heidenheim, Heidenheim, Germany. , (Germany)
  • 28 Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Australia. , (Australia)
  • 29 Medical Intensive Care Unit, ICMiD. Hospital Clínic de Barcelona, Barcelona, Spain. , (Spain)
  • 30 IDIBAPS, University of Barcelona, Barcelona, Spain. , (Spain)
  • 31 Intensive Care Unit, Nepean Hospital, Sydney, Australia. , (Australia)
  • 32 Department of Critical Care Medicine; Ghent University Hospital, Ghent, Belgium. , (Belgium)
  • 33 Faculty of Medicine, Universidad de Chile, Santiago, Chile. , (Chile)
  • 34 Department of Pharmacy, Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia. , (Malaysia)
  • 35 Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. , (Germany)
  • 36 Hospital Pharmacy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. , (Germany)
  • 37 Intensive Care Unit Department, University Hospital of Ioannina, Ioannina, Greece. , (Greece)
  • 38 Intensive Care Unit, Clinique Universitaire St Luc UCL, Brussels, Belgium. , (Belgium)
  • 39 Guy's and St Thomas Hospital, London, United Kingdom. , (United Kingdom)
  • 40 Intensive Care Unit, Nîmes University Hospital (Centre Hospitalo Universitaire Nimes), Nimes, France. , (France)
  • 41 Department of Nursing, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. , (Spain)
  • 42 Multidisciplinary Intensive Care Research Organization (MICRO), St James Hospital, Dublin, Ireland. , (Ireland)
  • 43 Department of Anesthesiology and Intensive Care, School of Medicine, International Islamic University Malaysia, Selangor, Malaysia. , (Malaysia)
  • 44 CIBERES, Vall d'Hebron Institute of Research, Barcelona, Spain. , (Spain)
  • 45 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia. , (Australia)
  • 46 Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia. , (Australia)
  • 47 Translational Research Institute, The University of Queensland, Buranda, Australia. , (Australia)
  • 48 Intensive Care Unit, Gold Coast University Hospital, Gold Coast, Australia. , (Australia)
  • 49 Intensive Care Unit, University Hospital Joan XXIII, Tarragona, Spain. , (Spain)
  • 50 Rovira i Virgili University, IISPV/CIBERES, Tarragona, Spain. , (Spain)
  • 51 Department of Pharmacy, General Hospital of Heidenheim, Heidenheim, Germany. , (Germany)
  • 52 Faculty of Medicine, An University of Queensland, New Orleans, Louisiana, USA.
  • 53 Intensive Care Unit, Ochsner Health System, New Orleans, Louisiana, USA.
  • 54 Pharmacy Department, Division of Medicines. Hospital Clínic de Barcelona, Barcelona, Spain. , (Spain)
  • 55 Nephrology, University Hospital of Ioannina, Ioannina, Greece. , (Greece)
Type
Published Article
Journal
Clinical Infectious Diseases
Publisher
Oxford University Press
Publication Date
Apr 26, 2021
Volume
72
Issue
8
Pages
1369–1378
Identifiers
DOI: 10.1093/cid/ciaa224
PMID: 32150603
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The optimal dosing of antibiotics in critically ill patients receiving renal replacement therapy (RRT) remains unclear. In this study, we describe the variability in RRT techniques and antibiotic dosing in critically ill patients receiving RRT and relate observed trough antibiotic concentrations to optimal targets. We performed a prospective, observational, multinational, pharmacokinetic study in 29 intensive care units from 14 countries. We collected demographic, clinical, and RRT data. We measured trough antibiotic concentrations of meropenem, piperacillin-tazobactam, and vancomycin and related them to high- and low-target trough concentrations. We studied 381 patients and obtained 508 trough antibiotic concentrations. There was wide variability (4-8-fold) in antibiotic dosing regimens, RRT prescription, and estimated endogenous renal function. The overall median estimated total renal clearance (eTRCL) was 50 mL/minute (interquartile range [IQR], 35-65) and higher eTRCL was associated with lower trough concentrations for all antibiotics (P < .05). The median (IQR) trough concentration for meropenem was 12.1 mg/L (7.9-18.8), piperacillin was 78.6 mg/L (49.5-127.3), tazobactam was 9.5 mg/L (6.3-14.2), and vancomycin was 14.3 mg/L (11.6-21.8). Trough concentrations failed to meet optimal higher limits in 26%, 36%, and 72% and optimal lower limits in 4%, 4%, and 55% of patients for meropenem, piperacillin, and vancomycin, respectively. In critically ill patients treated with RRT, antibiotic dosing regimens, RRT prescription, and eTRCL varied markedly and resulted in highly variable antibiotic concentrations that failed to meet therapeutic targets in many patients. © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected]

Report this publication

Statistics

Seen <100 times